Unique ID issued by UMIN | UMIN000046111 |
---|---|
Receipt number | R000052585 |
Scientific Title | Confirmation of calcium absorption promoting action in mannooligosaccharides |
Date of disclosure of the study information | 2022/12/01 |
Last modified on | 2023/04/25 07:12:35 |
Confirmation of calcium absorption promoting action in mannooligosaccharides
Confirmation of calcium absorption promoting action in mannooligosaccharides
Confirmation of calcium absorption promoting action in mannooligosaccharides
Confirmation of calcium absorption promoting action in mannooligosaccharides
Japan |
Healthy adult
Adult |
Others
NO
The objective of this study is to confirm the promotion of calcium absorption by mannooligosaccharides intake.
Efficacy
Excreted urinary calcium
Urinary deoxypyridinoline
Urinary NTx
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Intake of test drink 1 once a day for 1week
Intake of test drink 2 once a day for 1week
Intake of placebo drink once a day for 1week
20 | years-old | <= |
70 | years-old | >= |
Female
(1)Healthy female aged 20-70 years
(2)Subjects who have received a sufficient explanation of the purpose and contents of the examination, have the ability to consent, have well understood, volunteered to participate, and have signed the informed consent document
(1)Subjects who affected from chronic illness and are taking drugs
(2)Subjects who have bone-related diseases
(3)Subjects who have a medical history of diseases such as malignant tumor, heart failure, myocardial infarction, arrhythmia, liver dysfunction, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, urinary stones, etc.
(4)Subjects who are taiking supplements (including foods for specified health use and foods with functional claims)
(5)Subjects who regularly drink milk
(6)Subjects working in night shifts
(7)Subjects who who always have diarrhea
(8)Subjects who have a history of gastrointestinal disorders and gastrointestinal surgery that affect gastrointestinal absorption
(9)Subjects who have allergies to food ingredients contained in test foods
(10)Subjects who are pregnant, breastfeeding, or willing to become pregnant
(11)Subjects who have collected more than 200 mL of blood within 12 weeks prior to the screening test
(12)Subjects who participate in other clinical trials (food, pharmaceuticals and cosmetics), who have participated in other tests within one month of obtaining consent, or who are willing to participate
(13)Subjects who are judged as unsuitable for the study by the investigators
30
1st name | Yoshitaka |
Middle name | |
Last name | Iwama |
Nihonbashi Cardiology Clinic
Director
103-0001
Kyodo Bldg. #201, 12-4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo
03-5641-4133
yiwama@well-sleep.jp
1st name | Toshio |
Middle name | |
Last name | Kumao |
Ajinomoto AGF, INC.
Technology Development Dept. Technical Research and Development Institute
210-8681
1-1, Suzuki-cho Kawasaki-ku, Kawasaki-shi Kanagawa Pref.
080-3721-4520
toshio.kumaoh.hv8@agf.co.jp
KSO Corporation
Ajinomoto AGF, INC.
Technology Development Dept.
Technical Research and Development Institute
Profit organization
Ethical Committee of Kobuna Orthopedics Clinic
311-2, Gokanmachi, maebashishi, Gunma
027-261-7600
sagawa@mc-connect.co.jp
NO
2022 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2021 | Year | 10 | Month | 28 | Day |
2021 | Year | 10 | Month | 28 | Day |
2021 | Year | 11 | Month | 15 | Day |
2022 | Year | 03 | Month | 31 | Day |
2021 | Year | 11 | Month | 18 | Day |
2023 | Year | 04 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052585